Adma Biologics (ADMA) Net Margin (2011 - 2026)
Adma Biologics (ADMA) recorded Net Margin of 30.40% in Q2 2026, up 2.35 percentage points from 28.05% a year earlier but down 9.19 percentage points from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Net Margin (2011 - 2026) Analysis & Trends
On a TTM basis, Adma Biologics' Net Margin came in at 32.98% as of Jun 30, 2026, down 11.08 percentage points year-over-year; for FY2025, it came in at 28.80%, down 17.55 percentage points from FY2024.
- Annual Net Margin has a five-year change of +208.21 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at 46.35% in FY2024 (+57.29 pp), -10.94% in FY2023 (+31.84 pp), -42.77% in FY2022 (+45.74 pp) and -88.52% in FY2021 (+90.90 pp).
- Quarterly Net Margin has ranged from -85.93% in Q1 2022 to 95.19% in Q4 2024 over the past five years.
- On a year-over-year basis, Net Margin rose in five of the last eight quarters, with an average year-over-year change of +12.63 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 119.07 percentage points in Q4 2024, against a drop of 59.71 percentage points in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 39.59% (Q1 2026), 35.48% (Q4 2025) and 27.14% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Adma Biologics | 2.28 Bn | 1.86 Bn | 86.28 Mn | 30.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.40% |
| Mar 31, 2026 | 39.59% |
| Dec 31, 2025 | 35.48% |
| Sep 30, 2025 | 27.14% |
| Jun 30, 2025 | 28.05% |
| Mar 31, 2025 | 23.44% |
| Dec 31, 2024 | 95.19% |
| Sep 30, 2024 | 29.96% |
| Jun 30, 2024 | 29.91% |
| Mar 31, 2024 | 21.75% |
| Dec 31, 2023 | -23.88% |
| Sep 30, 2023 | 3.81% |
| Jun 30, 2023 | -10.60% |
| Mar 31, 2023 | -11.93% |
| Dec 31, 2022 | -24.47% |
| Sep 30, 2022 | -36.26% |
| Jun 30, 2022 | -40.60% |
| Mar 31, 2022 | -85.93% |
| Dec 31, 2021 | -63.11% |
| Sep 30, 2021 | -85.65% |
API Access
Adma Biologics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();